Janus Henderson Group’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230M Buy
5,965,125
+1,427,717
+31% +$52.7M 0.11% 177
2025
Q4
$161M Buy
4,537,408
+1,359,365
+43% +$38.2M 0.07% 216
2025
Q3
$45.6M Buy
3,178,043
+304,990
+11% +$3.61M 0.02% 429
2025
Q2
$20.6M Buy
2,873,053
+2,843,980
+9,782% +$15.8M 0.01% 562
2025
Q1
$188K Hold
29,073
﹤0.01% 2375
2024
Q4
$227K Buy
29,073
+13,300
+84% +$133K ﹤0.01% 2378
2024
Q3
$170K Hold
15,773
﹤0.01% 2471
2024
Q2
$133K Sell
15,773
-2,083,584
-99% -$15.8M ﹤0.01% 2475
2024
Q1
$14.1M Buy
2,099,357
+2,083,065
+12,786% +$12.9M 0.01% 624
2023
Q4
$95.9K Sell
16,292
-1,620,669
-99% -$12.4M ﹤0.01% 2527
2023
Q3
$16M Buy
1,636,961
+318,849
+24% +$3.78M 0.01% 578
2023
Q2
$15.6M Sell
1,318,112
-344,153
-21% -$3.95M 0.01% 599
2023
Q1
$17.9M Buy
1,662,265
+60,068
+4% +$768K 0.01% 596
2022
Q4
$18.5M Sell
1,602,197
-1,774,861
-53% -$22M 0.01% 584
2022
Q3
$50.4M Buy
3,377,058
+1,246,562
+59% +$17.1M 0.02% 515
2022
Q2
$19.2M Sell
2,130,496
-1,034,745
-33% -$7.06M 0.01% 572
2022
Q1
$23.7M Buy
3,165,241
+649,987
+26% +$4.53M 0.01% 712
2021
Q4
$21.6M Buy
2,515,254
+21,293
+0.9% +$185K 0.01% 770
2021
Q3
$21M Buy
2,493,961
+55,760
+2% +$427K 0.01% 780
2021
Q2
$19.8M Buy
2,438,201
+155,073
+7% +$1.31M 0.01% 786
2021
Q1
$20M Buy
2,283,128
+554,458
+32% +$5.34M 0.01% 768
2020
Q4
$19.4M Buy
1,728,670
+1,651,080
+2,128% +$18.1M 0.01% 756
2020
Q3
$715K Buy
+77,590
New +$809K ﹤0.01% 1178

Other funds holding COGT